0001104659-22-070674.txt : 20220613 0001104659-22-070674.hdr.sgml : 20220613 20220613210747 ACCESSION NUMBER: 0001104659-22-070674 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220610 FILED AS OF DATE: 20220613 DATE AS OF CHANGE: 20220613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Steven Clive CENTRAL INDEX KEY: 0001883325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40825 FILM NUMBER: 221013259 MAIL ADDRESS: STREET 1: C/O WARBY PARKER INC. STREET 2: 233 SPRING STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Warby Parker Inc. CENTRAL INDEX KEY: 0001504776 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 800423634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 847-7215 MAIL ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: JAND, Inc. DATE OF NAME CHANGE: 20101102 4 1 tm2218339-9_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-10 0 0001504776 Warby Parker Inc. WRBY 0001883325 Miller Steven Clive C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR EAST NEW YORK NY 10013 0 1 0 0 Chief Financial Officer Class A Common Stock 2022-06-10 4 M 0 12137 0 A 170506 D Class A Common Stock 2022-06-10 4 S 0 5084 14.64 D 165422 D Class A Common Stock 2022-06-13 4 S 0 7053 13.4217 D 158369 D Restricted Stock Units 2022-06-10 4 M 0 1981 0 D Class A Common Stock 1981 21131 D Restricted Stock Units 2022-06-10 4 M 0 2525 0 D Class A Common Stock 2525 16833 D Restricted Stock Units 2022-06-10 4 M 0 2535 0 D Class A Common Stock 2535 6759 D Restricted Stock Units 2022-06-10 4 M 0 5096 0 D Class A Common Stock 5096 64547 D Includes 925 shares acquired on May 14, 2022 under the Issuer's employee stock purchase plan in an exempt transaction pursuant to Rule 16b-3(c). These share sales are required by the Issuer's equity compensation plan to cover taxes due on restricted stock units ("RSUs") that vested. The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.13 to $14.04. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock. This filing relates to the occurrence of a RSU vesting event. The RSUs will vest in 48 monthly installments beginning on January 1, 2021 and will expire on January 27, 2028. The RSUs will vest in 48 monthly installments beginning on January 1, 2020 and will expire on November 19, 2026. The RSUs will vest in 48 monthly installments beginning on January 1, 2019 and will expire on March 28, 2026. The RSUs will vest in 48 monthly installments beginning on July 1, 2021 and will expire on June 14, 2031. /s/ Hyung Bak, Attorney-in-Fact 2022-06-13